BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7385 related articles for article (PubMed ID: 2004337)

  • 1. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications.
    el-Naggar AK; Ordóñez NG; Sara A; McLemore D; Batsakis JG
    Cancer; 1991 Apr; 67(8):2173-9. PubMed ID: 2004337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance].
    Li S
    Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms.
    Zalupski MM; Ryan JR; Ensley JF; Maciorowski Z; Pietraszkiewicz H; Hussein ME; Kukuruga M; Sundareson AS; Baker LH
    Cytometry; 1993 Nov; 14(8):922-30. PubMed ID: 8287735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft tissue vascular tumors. A flow cytometric DNA analysis.
    Fukunaga M; Shimoda T; Nikaido T; Ushigome S; Ishikawa E
    Cancer; 1993 Apr; 71(7):2233-41. PubMed ID: 8453543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors.
    Kroese MC; Rutgers DH; Wils IS; Van Unnik JA; Roholl PJ
    Cancer; 1990 Apr; 65(8):1782-8. PubMed ID: 2156603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact.
    Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
    Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and predictive validity of DNA image cytometry in soft tissue tumors].
    Bollmann R; Steinau HU; Bosse A
    Verh Dtsch Ges Pathol; 1998; 82():351-7. PubMed ID: 10095459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA analysis of vascular soft tissue tumors, including African endemic-type Kaposi's sarcoma.
    Eto H; Toriyama K; Tsuda N; Tagawa Y; Itakura H
    Hum Pathol; 1992 Sep; 23(9):1055-60. PubMed ID: 1516928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content as a predictor of clinical outcome in soft tissue sarcoma patients.
    Budach W; Budach V; Socha B; Stuschke M; Streffer C; Sack H
    Eur J Cancer; 1994; 30A(12):1815-21. PubMed ID: 7880612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma.
    Garcia JJ; Kramer MJ; Mackey ZB; O'Donnell RJ; Horvai AE
    Arch Pathol Lab Med; 2006 Mar; 130(3):343-8. PubMed ID: 16519562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
    Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
    Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity.
    el-Naggar AK; Garcia GM
    Cancer; 1992 Apr; 69(7):1721-8. PubMed ID: 1551057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue.
    Swanson PE; Wick MR
    Arch Pathol Lab Med; 1989 Jan; 113(1):55-60. PubMed ID: 2521288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the DNA content in the progression of recurrent and metastatic melanomas.
    Korabiowska M; Brinck U; Kotthaus I; Berger H; Droese M
    Anticancer Res; 2000; 20(4):2791-4. PubMed ID: 10953359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of DNA ploidy in childhood rhabdomyosarcoma.
    Jung WH; Jung SH; Yoo CJ; Kim YJ; Park C; Kim BS
    Yonsei Med J; 1994 Mar; 35(1):34-42. PubMed ID: 8009895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and proliferation index of soft tissue sarcomas determined by image cytometry of fresh frozen tissue.
    Herzberg AJ; Kerns BJ; Honkanen FA; Pence JC; Iglehart JD; Kinney RB
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S29-37. PubMed ID: 1575218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 370.